ResMed Inc
Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%
ResMed Global Devices by Quarter
Global Devices — Share of Quarterly Consolidated Revenue (Legacy through FY2026Q3, %) (%)
ResMed Global Devices: 51.0% in Q3 FY26, down 1.0 pts from a year earlier. That is the lowest of the 16 quarters on record here.
Where the Q3 FY26 figure comes from
“Q3 FY26 financial results YoY Revenue Trajectory Revenue by Revenue Segment by and Region Business ($ in millions) Revenue % by Segment $1,431.4 12% Devices Masks and other $1,291.7 51% 37% RCS Revenue % by Region U.S., Canada, & 12% Latin America Europe, Asia, & 31% Other 57% RCS (U.S. & Q3 FY25 Q3 FY26 Germany) Note: Data as of March 31, 2026. Resmed’s fiscal year end is”
Source: ResMed Q3 FY2026 Earnings Presentation (2026-04-30) ↗
Reported in ResMed Quarterly Earnings Presentations (Quarterly Business Mix Slide).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). ResMed Global Devices (%), quarterly Q4 FY22–Q3 FY26 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-global-mix-q
See every metric in the ResMed KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?